Benefit-risk assessment to support the FDA's decision on vaccines for SARS-CoV-2

被引：0
|
作者：
Yang, Hong [1 ]
机构：
[1] FDA, CBER, OBPV, Silver Spring, MD USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2023年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
243
引用
收藏
页码：103 / 103
页数：1
相关论文
共 50 条
  • [31] Maintaining Safety with SARS-CoV-2 Vaccines
    Castells, Mariana C.
    Phillips, Elizabeth J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (07): : 643 - 649
  • [32] Reinfection With SARS-CoV-2: Implications for Vaccines
    Cohen, Jeffrey, I
    Burbelo, Peter D.
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (11) : E4223 - E4228
  • [33] The variants of SARS-CoV-2 and the challenges of vaccines
    Han, Xiucui
    Ye, Qing
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (04) : 1366 - 1372
  • [34] SARS-CoV-2: Vaccines in the pandemic era
    Dan-Dan Li
    Qi-Han Li
    Military Medical Research, 2021, (02) : 238 - 252
  • [35] SARS-CoV-2 vaccines: evolution and escape
    Rivero, Ricardo H.
    Gonzalez, Marco
    Mattar, Salim
    REVISTA MVZ CORDOBA, 2021, 26 (03)
  • [36] Advanced Materials for SARS-CoV-2 Vaccines
    Mabrouk, Moustafa T.
    Huang, Wei-Chiao
    Martinez-Sobrido, Luis
    Lovell, Jonathan F.
    ADVANCED MATERIALS, 2022, 34 (12)
  • [37] The immunology of SARS-CoV-2 infections and vaccines
    Grigoryan, Lilit
    Pulendran, Bali
    SEMINARS IN IMMUNOLOGY, 2020, 50
  • [38] Immune Response to SARS-CoV-2 Vaccines
    Bellamkonda, Navya
    Lambe, Upendra Pradeep
    Sawant, Sonali
    Nandi, Shyam Sundar
    Chakraborty, Chiranjib
    Shukla, Deepak
    BIOMEDICINES, 2022, 10 (07)
  • [39] SARS-CoV-2 vaccines in patients with SLE
    Tang, Wei
    Askanase, Anca D.
    Khalili, Leila
    Merrill, Joan T.
    LUPUS SCIENCE & MEDICINE, 2021, 8 (01):
  • [40] SARS-CoV-2: vaccines in the pandemic era
    Li, Dan-Dan
    Li, Qi-Han
    MILITARY MEDICAL RESEARCH, 2021, 8 (01)
12345